Yale biotech spinoff Modifi Biosciences receives $2.4 million to continue research and development on novel cancer therapeutics
Yale researchers at biotech company Modifi Biosciences are developing a novel cancer therapy to treat glioblastoma - an aggressive form of brain cancer - earning them a Small Busin…